The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
EMED · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | MTEX | PAHC | EMED | AMPH |
|---|---|---|---|---|
| Moat Score (0–100) | 58 | 59 (highest) | 59 (highest) | 58 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 15 | 90 | 63 | 95 (highest) |
| Pricing power | 100 (highest) | 56 | 99 | 62 |
| Returns on capital | 84 (highest) | 62 | — | 19 |
| Balance-sheet safety | 28 | 33 (highest) | 28 | 32 |
| Capital allocation | 64 | 52 | 44 | 83 (highest) |
| No price data | No price data | No price data | 11% below value if growth stopped today | |
| Market cap | $13.8M | Not reported | $46329 | $1.2B |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filing date | FY2025 | FY2026 | FY2023 | FY2025 |